Figure 2.
Comparison of ex-miR-21 and ex-miR-92a levels between patients with GC and healthy volunteers. (A) Comparison of ex-miR-21 levels between patients with GC (n=129) and healthy volunteers (n=20). (B) Comparison of ex-miR-92a levels between patients with GC (n=129) and healthy volunteers (n=20). ex-, exosome-encapsulated; GC, gastric cancer; miR, microRNA.